Podcasts about cancer treatment

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

If you have a friend or family member diagnosed with cancer or another serious illness, all you want to do is help. But where do you start? What if you say the wrong thing or don't show up in the right ways? In this episode, we go over different ways to offer support. No matter what your strengths are, we have ideas to get you started.Sign up for our newsletter series on credit card debt.  Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Pennsylvania Governor Josh Shapiro is expanding on his promise to preserve vaccine access across the commonwealth… after a reversal on recommendations from the federal government. Pennsylvania researchers are pushing back against the recent announcement from the White House of a direct link between autism and the use of the painkiller acetaminophen, the active ingredient in Tylenol. Researchers at the University of Pennsylvania are exploring a treatment that uses a patient’s own body in a surprising way to fight cancer. CAR T-Cell Therapy: A Breakthrough in Cancer Treatment and the Path Ahead | The Spark House lawmakers approved background checks to purchase any type of firearm in Pennsylvania. The proposal faces long odds of passing the state Senate. Property owners in Pennsylvania who are worried about landslides and sinkholes may soon be able to breathe easier, after the state House voted to create a state-backed insurance program to cover them. As the federal government shutdown enters its third day, access to 400 National Park Service sites is varying on a park-by-park basis. Here in Central Pennsylvania, the Gettysburg National Military Park Museum and Visitor Center is remaining open and maintaining its regular hours for visitors. It's a different scene in Philadelphia. Thirty-three Pennsylvania counties will elect a sheriff on November 4th. And Lancaster is named to the list of "best small cities in America" as determined by WalletHub. Public media's federal funding has been revoked. Your support is now more vital than ever. Help power the independent journalism and trusted programming you find on WITF by making a gift of support now at www.witf.org/givenow.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

Send us a textTerry was a guest back in 2022 is back again to talk about his continuing cancer battle and his new book:  Four Truths and a Lie, Ancient Wisdom For Living Your Modern Purpose.*****Terry Tucker is an author and sought-after speaker who passionately believes in the transformative power of a good story to motivate, inspire, and encourage others. His purpose is to help people lead their uncommon and extraordinary lives.Combining his thirteen-year cancer journey with his diverse business, athletic coaching, and law enforcement expertise, Terry delivers compelling yet relatable presentations. His unique background and experiences allow him to offer a fresh perspective on leadership, mindset, motivation, and resilience for conferences, virtual events, panels, meetings, and seminars.Terry is the Founder of Motivational Check LLC. He has a Bachelor of Science in Business Administration from The Citadel and a Master's degree from Boston University. His journey has been a combination of distinct practices. He has been an NCAA Division I college basketball player, a marketing executive, a hospital administrator, a customer service manager, a SWAT Hostage Negotiator, a business owner, a high school basketball coach, and a cancer warrior.He is the author of Sustainable Excellence, Ten Principles To Leading Your Uncommon and Extraordinary Life, and Four Truths and a Lie, Ancient Wisdom For Living Your Modern Purpose. Terry is also a featured author in Perspectives on Cancer, Stories of Healing, Hope, & Resilience. He has been published in Authority, Thrive Global, and Human Capital Leadership magazines, along with being quoted and highlighted in the books Your Blueprint for Purpose by John Creekmur and Audaciousness, Your Journey To Living A Bold And Authentic Life by Maribel Ortega and Helen Strong. Terry has also developed the following 4 Truths to encourage, guide, and support the audiences he speaks with:1. Control your mind, or it will control you.2. Embrace the pain and discomfort we all experience in life and use it to make you a stronger and more resilient individual.3. You leave behind what you weave in other people's hearts.4. As long as you don't quit, you can never be defeated. *****If you would like to contact the show about being a guest, please email us at Dauna@bettertopodcast.comUpcoming guests can be found: https://dmneedom.com/upcoming-guest Follow us on Social MediaInstagram: https://www.instagram.com/author_d.m.needom/Facebook: https://www.facebook.com/bettertopodcastwithdmneedomIntro and Outro music compliments of Fast Suzi©2025 Better To...Podcast with D. M. Needom Support the show

It is essential for adolescents and young adults (AYAs) to have a foundation of care prior to discharge after their cancer treatment, and the multidisciplinary care team, including primary care providers (PCPs), must be equipped to support these patients. In this episode, CANCER BUZZ speaks with Scott J. Capozza, PT, MSPT, on his journey navigating care after cancer treatment as a young adult and his ASCO JCO Oncology Practice article, “Patient is Otherwise Healthy.” CANCER BUZZ then speaks with Melody Griffith, MSW, LMSW, Outpatient Adolescent and Young Adult (AYA) Oncology social worker at Mayo Clinic Arizona, on her role in patient navigation and how her department supports AYAs through their entire cancer continuum. CANCER BUZZ concludes with Cathy Lee-Miller, MD, director of AYA Oncology Clinic at the University of Wisconsin Carbone Cancer Center, on their cohort training program preparing PCPs for managing AYA survivorship care.    “The late effects for young adults are very real and a lot of times they are not recognized because we look otherwise healthy on the outside, but that belies what's going on internally.” - Scott J. Capozza, PT, MSPT   “We talk about post-traumatic stress, but also post-traumatic growth and what they bring with them and what they've learned through their process. It's not just the treatment, right? After treatment, there's a lot of years left to live.” - Melody Griffith, MSW, LMSW   “We really try and help empower these patients, particularly AYAs who maybe relied on their parents for their medical care before... We really try to spell that out for people so they can take responsibility and take charge of their own long-term health.” - Cathy Lee-Miller, MD   Scott J. Capozza, PT, MSPT Board Certified Clinical Specialist in Oncologic Physical Therapy  YNHH Outpatient Oncology Rehabilitation Services Smilow Cancer Hospital Adult Cancer Survivorship Clinic New Haven, CT   Melody Griffith, MSW, LMSW Outpatient Adolescent and Young Adult (AYA) Oncology Social Worker Mayo Clinic Arizona Phoenix, AZ   Cathy Lee-Miller, MD Director, AYA Oncology Clinic Associate Professor, Pediatric Hematology/Oncology/Transplant & Cellular Therapy University of Wisconsin Carbone Cancer Center Madison, WI    This podcast is part of the AYA Oncology Screening and Survivorship Services program, made possible through the support from The Arizona Clinical Oncology Society, Indiana Oncology Society, and Wisconsin Association of Hematology and Oncology. Resources: The Arizona Clinical Oncology Society: https://tacos.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources Indiana Oncology Society: https://inos.accc-cancer.org/resources/aya-cancer-resources Wisconsin Association of Hematology and Oncology: https://waho.accc-cancer.org/resources/adolescent-and-young-adult-cancer-resources

In this episode of the Revenue Builders Podcast, our hosts John Kaplan and John McMahon are joined by Steve Garraty, a tech sales leader and author who shares his inspiring journey from a troubled teen diagnosed with cancer to a successful career in sales leadership. Steve delves into his incredible story of resilience, how he overcame a devastating cancer diagnosis at 18, and how this battle shaped his personal and professional life. Highlighting key themes of gratitude, empathy, and the power of positive thinking, Steve discusses the impact of cancer on his leadership style and offers valuable advice for those facing personal challenges. The conversation also touches on the importance of relationships and knowing one's story. Steve's newly released book, Greatfruit, captures these life-changing experiences and provides further insights into his journey.ADDITIONAL RESOURCESConnect with Steve Garraty: https://www.linkedin.com/in/stevegarratyGet Greatfruit at Barnes & Noble: https://www.barnesandnoble.com/w/greatfruit-steve-garraty/1147081359 Get Greatfruit on Amazon: https://a.co/d/2sWFNEwExplore Force Management's Free SKO Planning Resources: https://hubs.li/Q03K94cs0Read the Guide on Six Critical Priorities for Revenue Leadership in 2026: https://hubs.li/Q03JN74V0Watch Force Management's Panel Discussion on Growth, Valuation and Execution: https://bit.ly/4p6kyGSEnjoying the podcast? Sign up to receive new episodes straight to your inbox: https://hubs.li/Q02R10xN0HERE ARE SOME KEY SECTIONS TO CHECK OUT[00:01:13] Steve's Early Life and Cancer Diagnosis[00:01:39] The Battle with Cancer[00:02:02] Life After Cancer: Career and Family[00:03:04] Writing 'Great Fruit' and Reconnecting with John[00:08:08] Steve's Journey Through Chemotherapy[00:10:21] The Mental and Physical Toll of Cancer Treatment[00:22:08] Finding Blessings Amidst Tragedy[00:26:33] The Importance of Relationships and Leadership[00:34:49] The Brutal Interview Process[00:36:02] Revealing the Cancer Story[00:39:17] Writing the Book: A 37-Year Journey[00:46:58] Mindset and Health: The Power of Positive Thinking[00:54:19] Impact on Sales Career and Leadership[00:57:39] Advice for Overcoming Personal ChallengesHIGHLIGHT QUOTES[00:01:48] “He went from victim to Victor, from asking ‘Why me?' to ‘Why not me?'”[00:21:32] “Blessings can be found amidst the tragedies.”[00:25:11] “Every day is a gift.”[00:26:20] “You never know what people are going through—everybody's got a story.”[00:27:51] “The greatest sign of leadership is when your people don't need you anymore.”[01:00:48] “If you're going through something tough, the worst thing you can do is isolate.”[01:01:14] “Just show up. You don't have to say anything.”[00:27:09] “I want to help people achieve success—not for me, but for them.”[00:25:36] “Perspective is what turns adversity into a blessing.” Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

When someone finishes a cancer treatment, it can feel like the end of the story. For many, it may just be the beginning–risk of recurrence looms, long-term medications (and their side effects) begin, and it’s hard to get your bearings. What do you really need to know?In this candid conversation, Katie sits down with Dr. Lillian Smyth, Senior Vice President and Global Development Head for Breast Cancer at Eli Lilly and Company, and LaShae Rolle, a breast cancer survivor, public health researcher, and powerlifter. Together, they explore what life after breast cancer treatment really looks like: from follow-up care and managing side effects to navigating fears about recurrence and finding strength in advocacy.This episode—created in partnership with Eli Lilly—is about more than medicine. It’s about empowerment: knowing your “normal,” asking the right questions, and embracing life following cancer treatment.See omnystudio.com/listener for privacy information.

As lawmakers trade blame for the government shutdown, the economy is feeling the impact. Thousands of federal workers have been furloughed with firings potentially on the way. National Guard troops have been sent to Memphis. We have an update on twin hurricanes Imedla and Humberto. Plus, the Trump administration's initiative to end childhood cancer with AI. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Nicole Paulk is the CEO, Founder, and President of Siren Biotechnology and has dedicated her career to advancing the field of gene therapy. With nearly two decades of expertise, Nicole has been at the forefront of developing cutting-edge advances to propel the field of gene therapy forward for a wide range of diseases. Nicole has held various leadership positions in academia and industry and most notably was an Assistant Professor of AAV Gene Therapy in the UCSF Department of Biochemistry & Biophysics before leaving to found Siren. Nicole has a B.S. in Medical Microbiology, a Ph.D. in Viral Gene Therapy and Regenerative Medicine from OHSU and completed her Postdoctoral Fellowship and Instructorship in Human Gene Therapy at Stanford University prior to starting her lab at UCSF. Nicole is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing, directed evolution for novel engineered capsid evolution, and comparative multi-omic approaches to interrogate translational AAV biology.

Did you know that Prostate Cancer is one of the most common cancers among men?  It is also the second leading cause of cancer death in men, behind only lung cancer. To raise awareness and learn more about prostate cancer, I had the pleasure to sit down with Dr. David Hepps of St. Clair Medical Group Urology. In this episode, we discuss practical steps men can take for early detection and better outcomes, as well as how St. Clair supports patients and families through collaborative care and quality-of-life considerations. We also review treatment options such as robotic surgery, active surveillance, and the BioProtect Balloon that helps protect healthy tissue during radiation treatment.  To  schedule an appointment with Dr. Hepps or another St. Clair Medical Group Urology provider, call 412-942-4100.   Thank you St. Clair Health for sponsoring this episode. To learn more about St. Clair Health,  visit https://www.stclair.org/ All episodes are available on Youtube at http://www.youtube.com/@Spillwithmejennyd as well as all the major audio platforms. Interested in being a guest or sponsor on Spill with Me Jenny D Show? Contact Kelli Komondor at kelli@k2creativellc.com To view previous episodes and fill out a disclaimer to be a guest Under Tell us Your Story visit...https://www.spillwithmejennyd.com/

Lumalala ba ang peer pressure as we get older? Bumababa ba ang social battery habang tumatanda? Pag-usapan natin sa pinakabagong episode Reddit Set Go ng Silly Gang Sa Gabi! Be a member on patreon.com/sillygangsagabi for early vidcast release PLUS MORE adulting chikahan at ang newest Patreon exclusive na Kwentanong! Labanan ang FOMO! Be a Ka-Okra Pro at Pro Max member on patreon.com/sillygangsagabi! Subscribe na dahil part of your subscription goes to our chosen organization for the month of October ang Cancer Treatment and Support Foundation!CERTIFIED KA-OKRA TO DO LIST:✅GIVE THE GIFT OF GOOD VIBES: patreon.com/sillygangsagabi/gift ✅TAP the FOLLOW button and NOTIFICATION BELL here on SPOTIFY RATE this podcast with 5 STARS! ⭐⭐⭐⭐⭐✅Join the GAME for a chance to win Php150! CLICK here to join our FB group

Should men with prostate cancer get vaccinated? Every health decision feels weightier during treatment—including vaccines. In this episode, Dr. Stephen Petteruti takes an evidence-based look at vaccines during prostate cancer treatment, examining how common shots: COVID, flu, tetanus, pneumococcal, hepatitis, and shingles, affect the immune system when it's already under pressure.He explores which vaccines may strengthen the immune system, which may create unnecessary risks, and how these choices fit into a personalized plan for living well with prostate cancer.This episode is designed to empower men with knowledge, so they can make decisions with confidence and keep their focus on living stronger, longer. Tune in now: Should You Get Vaccines During Prostate Cancer Treatment? Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

For decades, Dr. Bruce Levine has been at the forefront of cancer research, pioneering CAR T-cell therapy—a treatment that harnesses a patient’s own immune system to fight cancer. On a recent conversation with Asia Tabb, Levine shared his journey and the promise of this innovative therapy.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

If you were given some of the worst news in the world, wouldn't you expect your doctors to use every tool available?What if one of those tools could save millions of lives—and the science is already here?The world's largest medical cannabis and cancer study—10,000 papers, ranked in the top 5% globally—shows overwhelming evidence that cannabis has medical benefits. If fully embraced, its impact on patients and medicine could be transformative. As science continues to unfold, sometimes it takes skeptics to dive deep and uncover what's truly there, even when powerful interests push back.This week we sit down with Ryan Castle, Research Director at Whole Health Oncology Institute, to discuss:Medical cannabis: efficacy, placebo, and why it matters less than you thinkHow this study is being used in rescheduling effortsHow vested interests fuel anti-cannabis researchChapters00:00 Introduction to Medical Cannabis Research03:06 Ryan Castle's Journey into Cannabis Research05:58 The Meta-Analysis Process Explained09:00 Understanding the Data and Its Implications11:54 Skepticism and the Shift in Perspective15:01 Consensus in Medical Cannabis Research18:04 Nuances in Cancer Treatment and Cannabis20:55 Biomarkers and Inflammatory Responses22:56 Exploring Cannabis and Cancer Outcomes29:37 Bridging the Gap: Patient-Reported Outcomes35:32 The Future of Medical Cannabis Research45:34 The Cancer Playbook: Empowering Patients SummaryIn this episode, Bryan Fields and Kellan Finney engage with Ryan Castle, Research Director at Whole Health Oncology Institute, to explore the evolving landscape of medical cannabis research. Ryan shares his journey from skepticism to advocacy, detailing the extensive meta-analysis he conducted on the efficacy of cannabis in treating various symptoms and conditions, particularly in oncology. The conversation delves into the challenges of measuring effectiveness, the importance of patient-reported outcomes, and the need for a shift in medical perspectives towards cannabis as a legitimate treatment option. Ryan emphasizes the potential impact of policy changes and the importance of transparency in research, while also discussing the Cancer Playbook initiative aimed at empowering patients with data-driven insights. TakeawaysRyan Castle initially set out to prove that cannabis doesn't work.His extensive research revealed that cannabis is effective for a wide range of conditions.The meta-analysis included over 10,000 studies and 800,000 data points.Cannabis showed efficacy not just for symptoms but also for cancer treatment.Patient-reported outcomes are crucial for understanding cannabis effectiveness.The study found that cannabis can help reduce opioid dependency.There is a significant need for a shift in medical perspectives on cannabis.Transparency in research is essential for building trust in findings.The health impact assessment could reveal the broader benefits of cannabis.The Cancer Playbook initiative aims to empower patients with data-driven insights.Guest Linkshttps://wholehealthoncologyinstitute.com/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.

In this episode, Talaya sits down with Dr. Fazlur Rahman, a retired oncologist with a remarkable 35-year career spent serving communities in San Angelo, Texas. An author and advocate for patient-centered medicine, Dr. Rahman shares his invaluable insights on what's missing in modern healthcare and how we can bring it back.This is more than a medical conversation; it's a deep exploration of the human side of oncology for anyone navigating cancer, from patients and caregivers to future oncologists. Dr. Rahman shares powerful stories and lessons from a career dedicated to compassionate care.In this episode, we dive into:The Power of Empathy: Why Dr. Rahman believes a compassionate "bedside manner" is as critical as any treatment.Rural Health Barriers: Navigating the unique logistical, cultural, and financial challenges of cancer care in underserved areas.The Patient's Struggle: An honest discussion on the human and financial toll of a cancer diagnosis.Ethical Decisions: Dr. Rahman's perspective on the difficult choices patients and doctors face in modern healthcare.✨Timestamp Highlights:04:34 The Importance of Empathy in Medicine08:05 Dr. Rahman's Books and Writing11:36 Challenges in Cancer Care19:23 Barriers in Rural Cancer Care25:29 Financial and Ethical Struggles42:57 Advice for Future OncologistsTranscript: https://bit.ly/podscript172Connect & Engage with Dr. Rahman:Website: https://fazlurrahmanmd.com/

A retired nurse from Niles becomes the first patient at Northwestern Medicine to receive a new treatment for an advanced eye cancer. 66-year-old Bozena Wojtach was diagnosed with uveal melanoma, a rare form of eye cancer, last year.

A retired nurse from Niles becomes the first patient at Northwestern Medicine to receive a new treatment for an advanced eye cancer. 66-year-old Bozena Wojtach was diagnosed with uveal melanoma, a rare form of eye cancer, last year.

A retired nurse from Niles becomes the first patient at Northwestern Medicine to receive a new treatment for an advanced eye cancer. 66-year-old Bozena Wojtach was diagnosed with uveal melanoma, a rare form of eye cancer, last year.

The Kearney Regional Medical Center – owned by Bryan Health – and Cancer Partners of Nebraska are coming together to open the Kearney Cancer Center, a 25,000-square-foot facility dedicated to cancer treatment. The center includes a positron emission tomography (PET) scanner to detect early signs of cancer, a linear accelerator for delivering radiation to treat tumors, and infusion bays with views of Yanney Park for chemotherapy patients. It will also offer on-site lab and diagnostic imaging, access to national clinical trials and certified mastectomy fitting.

Catch Up on the latest leading news stories around the country with Mandy Wiener on Midday Report every weekday from 12h00 - 13h00 The Midday Report with Mandy Wiener is 702 and CapeTalk’s flagship news show, your hour of essential news radio. The show is podcasted every weekday, allowing you to catch up with a 60-minute weekday wrap of the day's main news. It's packed with fast-paced interviews with the day’s newsmakers, as well as those who can make sense of the news and explain what's happening in your world. All the interviews are podcasted for you to catch up and listen to. Thank you for listening to this podcast of The Midday Report Listen live on weekdays between 12:00 and 13:00 (SA Time) to The Midday Report broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk https://buff.ly/NnFM3Nk For more from The Midday Report go to https://buff.ly/BTGmL9H and find all the catch-up podcasts here https://buff.ly/LcbDdFI Subscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk See omnystudio.com/listener for privacy information.

In this week's Talking Health, Jessica is joined by Dr Juho Jalkanen – Chief Executive Officer at Faron Pharmaceuticals, to discuss the clinical trials of bexmarilimab for blood cancer treatment.

The Kearney Regional Medical Center – owned by Bryan Health – and Cancer Partners of Nebraska are coming together to open the Kearney Cancer Center, a 25,000-square-foot facility dedicated to cancer treatment. The center includes a positron emission tomography (PET) scanner to detect early signs of cancer, a linear accelerator for delivering radiation to treat tumors, and infusion bays with views of Yanney Park for chemotherapy patients. It will also offer on-site lab and diagnostic imaging, access to national clinical trials and certified mastectomy fitting.

On today's episode of Integrative Cancer Solutions Dr. Michael Karlfeldt is joined by Maike Winkelmann. Maike shares her journey with cancer, it is a powerful testament to resilience and self-advocacy. Diagnosed initially in 2007 while raising a young daughter, Maike faced a recurrence in 2020, which led to the removal of her left breast. Despite the emotional and physical toll, she refused chemotherapy, opting instead for radiation and a personalized treatment plan that combined conventional and alternative approaches. Her story begins with the shock of diagnosis and the challenges of navigating treatment options, all while managing the responsibilities of motherhood and the weight of uncertainty about her future. When her cancer returned in 2023, Maike experienced pain, swelling, and a grim prognosis as metastasis was discovered in her bones, head, and backbone. Doctors initially dismissed her symptoms, but a new scan revealed the extent of the disease. She underwent further radiation and faced significant complications, including fluid accumulation in her lungs. During this difficult period, Maike found hope and inspiration in Jane McClelland's book, which motivated her to become a researcher and advocate for her own healing, determined to explore every possible avenue for recovery. Maike's comprehensive treatment plan is a blend of strict dietary protocols, natural supplements, and off-label drugs such as Metformin and Berberine, aimed at blocking cancer pathways and targeting cancer stem cells. She describes the importance of a starvation phase—avoiding sugar, animal protein, and certain amino acids—followed by a ferroptosis phase, which uses specific fats to induce targeted oxidation of cancer cell membranes. The process is demanding, requiring careful monitoring and frequent adjustments based on her body's response, as well as significant financial and logistical effort to access the necessary treatments and support. Despite the challenges, Maike's perseverance led to remarkable improvement. Within nine months, she progressed from being nearly bedridden to swimming and snorkeling, regaining mobility and quality of life. She credits her recovery not only to the physical aspects of her protocol but also to the mental and emotional support she received from her community and the stress-free environment she created for herself. Her story underscores the importance of holistic healing, where emotional well-being and community support play a crucial role alongside medical interventions. Throughout her journey, Maike emphasizes the individualized nature of her treatment, the need for professional guidance, and the importance of hope. She has inspired others facing similar challenges to revisit their own treatment plans and to believe in the possibility of improvement, even in severe cases. Her experience highlights the power of personalized medicine, the value of self-advocacy, and the profound impact of maintaining hope and determination in the face of adversity.Maike Winkelmann shares her journey of battling cancer since 2007, including a recurrence in 2020 and 2023, and her decision to refuse chemotherapy in favor of a personalized treatment plan.She describes combining conventional medicine with alternative therapies, such as a strict diet, natural supplements, and off-label drugs like Metformin and Berberine.Maike emphasizes the importance of targeting cancer stem cells and using ferroptosis therapy, which involves specific dietary phases to induce cancer cell death.Despite significant challenges, including pain, mobility issues, and financial hurdles, she experiences remarkable improvement and regains her ability to swim and snorkel.Her story highlights the power of self-advocacy, hope, and the impact of personalized, holistic approaches to cancer treatment.Grab my book A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health Threat - https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 Unleashing 10X Power: A Revolutionary Approach to Conquering Cancerhttps://store.thekarlfeldtcenter.com/products/unleashing-10x-power-Price: $24.99-100% Off Discount Code: CANCERPODCAST1Healing Within: Unraveling the Emotional Roots of Cancerhttps://store.thekarlfeldtcenter.com/products/healing-within-Price: $24.99-100% Off Discount Code: CANCERPODCAST2----Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I'm joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today's standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.Time-Stamped Highlights00:00 – Why fewer incisions + faster recovery are now real in prostate surgery05:40 – Work–life changes that improved health (sleep, exercise, biking)09:10 – Open vs. robotic: why reproducibility (teachability) matters11:05 – Robotics adoption curve: from early resistance to mainstream19:05 – Outcomes today: continence and erections after modern surgery20:10 – “Yes, I'm a surgeon—and here's my bias.” Radical honesty with patients22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT34:00 – Dexterity & visualization: why robots spare nerves with less trauma35:10 – Real-time margin assessment during surgery to reduce positives40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential52:30 – How to find Dr. Stifelman & closing advice

Dr. Derya Unutmaz joins Dr. Buck Joffrey to discuss the critical role of T cells in the immune system, their changes with aging, and the implications for chronic diseases. He emphasizes the importance of thymus regeneration and the microbiome's influence on health. The discussion also covers advancements in engineering immune cells for cancer treatment and the potential of AI in revolutionizing aging research and drug discovery. Unutmaz expresses optimism about the future of aging research, highlighting the need for a shift in how aging is perceived in the medical community. Learn more about Dr. Derya Unutmaz: https://www.jax.org/research-and-faculty/faculty/derya-unutmaz - Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0 Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/

MIT researchers developed a device for targeted bladder cancer drug delivery, leading to the creation of TARIS Biomedical, which was later acquired by Johnson & Johnson. The device, designed to integrate with existing urological procedures, delivers medication directly to the bladder over two weeks and is removed with a standard cystoscope. Clinical trials showed that over 80 percent of high-risk, non-muscle-invasive bladder cancer patients had no evidence of disease after treatment, with more than half remaining cancer-free at nine months. The system received FDA approval and is being considered for use in other diseases.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.

The high cost associated with cancer diagnosis, treatment, and survivorship makes the burden of financial toxicity an unavoidable reality for many patients—and makes financial navigators central to the delivery of high-quality cancer care. In this vodcast episode, CANCER BUZZ speaks with Heather Simpson, BCPA, patient financial navigator lead, who shares her experience using the ACCC Financial Advocacy Network's financial advocacy services guidelines assessment tool to pinpoint financial navigation challenges within her cancer program. Heather Simpson, BCPA Patient Financial Navigator Lead              Allina Health Cancer Institute   River Falls, WI “When [ACCC] came out with a gap assessment tool in 2024...it allowed us to see where we had hit the mark with our program and where we had some gaps we could take care of to really be in line with the [Financial Advocacy Network's] guidelines.” Resources: Financial Advocacy Guidelines Financial Advocacy Services Assessment Tool Financial Advocacy Services Guidelines Assessment Tool User Guide In the Field: Practical Financial Advocacy Strategies for Supporting Cancer Patients Oncology Reimbursement Meetings This podcast is made possible by funding and support provided by Genentech, Eisai, Pfizer, and Regeneron and in partnership with AONN+, NPAF, Triage Cancer, and CancerCare.  

This week on Health Matters, Courtney talks with urologic oncologist Dr. Michael Feuerstein of Columbia and NewYork-Presbyterian The One, a new center for advanced care in Westchester, to discuss the importance of screening for prostate cancer. Dr. Feuerstein explains how blood tests work to detect prostate cancer, explores the latest advancements in treatment, and debunks common myths and misunderstandings about prostate health. ___Dr. Michael Feuerstein, MD, MPH, is the chief of urology at NewYork-Presbyterian Westchester and assistant professor in the Department of Urology at Columbia University Vagelos College of Physicians and Surgeons. Dr. Feuerstein is a board-certified urologist with over ten years of experience, specializing in minimally-invasive surgery for prostate, kidney, and bladder cancer. He received his medical degree and completed his urology residency training at Albany Medical Center. He completed a two-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center and received a master's degree in public health at the Columbia Mailman School of Public Health. Dr. Feuerstein's research focuses on improving quality of care and quality of life for patients diagnosed with urologic cancers. Dr. Feuerstein provides care at NewYork-Presbyterian The One, a state-of-the-art center for advanced care with doctors from Columbia in Westchester. The facility offers adult and pediatric care spanning more than 90 specialties and subspecialties, so patients can find the care they and their families need in one convenient location.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Welcome to another powerful episode of Navigating Cancer TOGETHER, hosted by Talaya Dendy.In this episode, we shine a spotlight on prostate cancer awareness, the critical issue of health disparities, and the vital importance of open conversations within the Black and African American community. Talaya is joined by a remarkable guest, Christopher Shaddock, a veteran and prostate cancer survivor who shares his powerful personal journey. From his unique experience living in Iceland to his candid discussion about the emotional and physical impacts of his diagnosis, Christopher's story is one of determination, advocacy, and hope.This episode is a must-listen for men, caregivers, and advocates who want to understand the unique challenges of a prostate cancer diagnosis and the power of sharing one's story and creating a domino effect.✨Highlights from the show:3:12 Christopher shares his unique experience living in Iceland9:49 Christopher's prostate cancer diagnosis story10:55 The emotional impact of diagnosis and treatment16:39 Side effects of prostate cancer treatment: what men should know24:34 Addressing health disparities and barriers for African American men30:25 The importance of support groups and advocacy32:23 The “domino effect” of sharing your story and inspiring othersTranscript: https://bit.ly/podscript171ResourcesThe Silent Killer - https://www.silentkillerdoc.comThe Ties That Bind - https://www.bluechildentertainment.com/the-ties-that-bind-crowdfundingZero Prostate Cancer - https://zerocancer.org/black-menRespond Study - https://www.respondstudy.org

Ep 65 | Why Algae Is the Missing Link in Your Health with Catharine ArnstonLooking for more energy, detox, and glowing skin? Algae may be holding the upgrade your body's been craving.In this episode, I sit down with Catharine Arnston, founder of EnergyBits, to talk about the powerhouse duo: spirulina + chlorella. We cover:12:09 – Why algae is a food not a supplement16:15 – My personal algae story & how Catharine and I met20:00 – How this algae is different than the one that shuts down your beach22:51 – Spirulina vs. Chlorella: what's the difference?28:35 – The science of algae & cancer prevention45:40 – How algae supports menopause, mitochondria & brain health1:03:10 – Mold, detox, and why chlorella is “health insurance”Catharine's passion for algae is contagious. You'll hear why NASA and biohackers worldwide swear by these tiny green tablets and the science behind them.✨ Takeaways:Spirulina = energy + focus + proteinChlorella = detox + recovery + mold/heavy metal supportAlgae is food, not a supplement: nutrient-dense, effortless, sustainableMeet Catharine Arnston:Catharine Arnston is an expert in algae nutrition, a wellness thought leader, an experienced entrepreneur, and a sought-after speaker. Catharine has a PhD, MBA, BA Hons, and is a board-certified health coach.Catharine's journey into the fascinating world of algae began in 2008 when her younger sister was diagnosed with breast cancer and advised by her oncologist that an alkaline diet would improve her healing. Catharine left her 25- year corporate career, leading her to algae - the most alkaline, chlorophyll-rich, high-protein, nutrient-dense food in the world. When Catharine learned that algae's vast healing properties were documented in tens of thousands of scientific studies but that none of these studies or benefits were known outside of Asia, she knew she needed to do something. And so ENERGYbits® was born. Catharine has spent the last fifteen years researching algae, writing papers, giving presentations, lecturing at conferences, and speaking on 300+ podcasts to explain the benefits of algae. To do this, she read thousands of scientific papers that detailed, validated, and confirmed algae's nutritional, health, longevity, and global benefits.  It is Catharine's vision and passion to change this and her PhD in natural health has given her the scientific fluency that allows her to explain algae with such simplicity and clarity, it quickly becomes obvious why algae is something we all urgently need. Resources:

In episode 93 of the Summits Podcast, co-hosts Vince Todd, Jr. and Daniel Abdallah are joined by Dr. Nur Damayanti, cancer researcher at IU School of Medicine. Tune in as Dr. Damayanti shares the personal cancer diagnosis that changed the trajectory of her career and the Heroes Foundation funding that is supporting her project to study new treatment methods for children with rare brain cancers. Learn more about recent Heroes Foundation gifts: https://www.heroesfoundation.org/the-heroes-foundation-has-awarded-nine-exciting-indiana-cancer-projects-with-223500-in-funding/

Christian Kollmannsberger joins us to walk through decades of advances in advanced testis cancer.

Genetics are foundational to much of cancer treatment, and now both the environment surrounding the tumor as well as analysis of cancer cells shed into the blood may also be used to inform treatment as well. That's according to studies … A combination of strategies help determine best cancer treatment strategies, Elizabeth Tracey reports Read More »

See omnystudio.com/listener for privacy information.

Prostate cancer is the most common cancer diagnosed in men and the five year survival rate is 97%.

In this episode I'm really excited to introduce you to Dr. Nasha Winters, who is author of the book "The Metabolic Approach to Cancer." She's a naturopathic doctor and founder of Metabolic Regen University and has created a metabolic approach to helping people prevent and address cancer and metabolic health disorders. I'm so glad she's here with me on How Humans Heal today. Because Dr. Nasha and I are both naturopathic doctors and graduated from naturopathic medical school at a similar time, our paths have crossed many times over the years. We are both passionate about sharing the message that health can be achieved by addressing the root cause of the health issue. We help patients figure out what's going on under the surface and help them understand what that means in terms of what they can implement to make a difference, especially related to cancer. Dr. Nasha's teaches around the world to both lay audiences and professional audiences, and created the Metabolic Regen University as a way to train clinicians in her approach to cancer. In this episode, Dr. Nasha shares her personal experience with ovarian cancer, how she healed herself, and how that inspired her to become a naturopathic doctor. We talk about high risk HPV related cancer, and cancer in general – how to think about it differently, and non-conventional ways to support healing. If you or someone you know is dealing with cancer, or at risk of cancer, this is an essential interview to listen to in your research process to identify alternative and integrative ways to prevent and address cancer, alongside conventional cancer treatment or if/when conventional approaches fail. We're here to help you! LINKS FROM THE EPISODE:   Connect with Dr. Winters: https://metabolicregen.com/    Join Dr. Doni's “Say Goodbye To HPV” Program: https://hpv.doctordoni.com/hpv/checkout-12week-program   Sign up For Dr. Doni's Masterclasses: https://doctordoni.com/masterclasses/    Schedule A Chat With Dr. Doni: https://intakeq.com/new/hhsnib/vuaovx    Read the full episode notes and find more information: https://doctordoni.com/blog/podcasts/ MORE RESOURCES FROM DR. DONI:   Quick links to social media, free guides and programs, and more: https://doctordoni.com/links     Disclosure: Some of the links in this post are product links and affiliate links and if you go through them to make a purchase I will earn a commission at no cost to you. Keep in mind that I link these companies and their products because of their quality and not because of the commission I receive from your purchases. The decision is yours, and whether or not you decide to buy something is completely up to you.

What if the most powerful cancer treatment costs nothing and has been hiding in plain sight for over a century?Join Dr. Katie Deming MD as she sits down with Dr. Nasha Winters, who survived terminal ovarian cancer at age 19 without conventional treatment. Dr. Winters now trains doctors worldwide in metabolic approaches that challenge everything we've been taught about cancer and healing.Dr. Deming brings her insider perspective from 20 years in conventional oncology, while Dr. Winters reveals why she accidentally discovered one of medicine's most suppressed healing tools. They examine the fascinating battle between two cancer theories that will completely change how you think about your health and why the losing theory from 100 years ago might hold the key to everything.Chapters:00:05:25 - Metabolic vs. Genetic Theories of Cancer00:15:14 - Stage 4 Ovarian Cancer at 1900:23:32 - Functional Medicine vs. Metabolic Approach00:34:44 - Fasting as a Healing Tool00:47:59 - The Future of Cancer CareIf you're overwhelmed by conflicting health advice, wondering why disease rates keep climbing despite medical "progress," or feeling like something crucial is missing from wellness conversations, this conversation cuts through the confusion. You'll discover Dr. Winters' systematic approach that identifies what's really driving illness in your unique body. Listen and learn about an ancient practice that modern medicine abandoned, one that could transform your relationship with healing forever. Metabolic Health Day Conference: https://metabolichealthday.life/WATCH on YOUTUBE: https://youtu.be/lOKhROiI-MgAccess the FREE Water Fasting Masterclass Now: https://www.katiedeming.com/the-healing-power-of-fasting/ Transform your hydration with the system that delivers filtered, mineralized, and structured water all in one. Spring Aqua System: https://springaqua.info/drkatieMORE FROM KATIE DEMING M.D. Work with Dr. Katie: www.katiedeming.comEmail: INFO@KATIEDEMING.COM 6 Pillars of Healing Cancer Workshop Series - Click Here to Enroll Follow Dr. Katie Deming on Instagram: https://www.instagram.com/katiedemingmd/ Watch on Youtube: https://youtube.com/playlist?list=PL5LplU70TE9i01tW_7Tozi8b6X6rGBKA2&si=ZXLy5PjM7daD6AV5 Please Support the Show Share this episode with a friend or family member Give a Review on Spotify Give a Review on Apple Podcast DISCLAIMER: The Born to Heal Podcast is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare provider.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ##FDA approves new drug for rare genetic disorderThe FDA has recently approved a new drug for the treatment of a rare genetic disorder. This drug has shown promising results in clinical trials and is expected to provide much-needed relief for patients suffering from this condition. ##Major pharmaceutical company announces mergerA major pharmaceutical company has announced plans to merge with another company in the industry. This merger is expected to create a powerhouse in the pharmaceutical world, with the potential for significant growth and innovation. ##Biotech startup secures funding for groundbreaking researchA biotech startup has recently secured a substantial amount of funding to support their groundbreaking research in a new area of biotechnology. This funding will allow the company to further develop their technology and bring it to market in the near future. ##FDA issues warning about potential side effects of popular medicationThe FDA has issued a warning about potential side effects of a popular medication that is commonly used to treat a variety of conditions. Patients are advised to speak with their healthcare provider if they have any concerns about taking this medication. ##Pharma company announces breakthrough in cancer treatmentA pharmaceutical company has announced a major breakthrough in the treatment of cancer. Their new therapy has shown promising results in clinical trials and has the potential to significantly improve outcomes for cancer patients. ##Biotech firm partners with university on new drug developmentA biotech firm has partnered with a university on a new drug development project. This collaboration brings together the expertise of both organizations to advance research and bring new treatments to market. ##FDA approves expanded use of existing medicationThe FDA has approved the expanded use of an existing medication for the treatment of a different condition. This decision is based on new research showing the effectiveness of this medication in treating this additional condition.

This week, Bobbi Conner talks with MUSC's Dr. Stacey Maurer about getting back to daily life after cancer treatment.

Do you like hearing interviews with world-changers?  Today you'll meet Dr. Nathan Goodyear who is with the Williams Cancer Institute where they are having phenomenal results with their treatments.  Dr. Goodyear will be sharing how his faith has intersected his profession his entire life.  Wonderful episode!Reach Out to Me:Website: www.dontignorethenudge.comPatreon: www.patreon.com/dontignorethenudgeIG: @dontignorethenudgepodcastPrivate FB group to WATCH interviews: www.dontignorethenudge.com/facebook__________________________________________________________________________________________Business/Personal Coaching with Cori:www.corifreeman.com(951) 923-2674Reach Out to Nathan Goodyear, MD:https://williamscancerinstitute.com/https://www.off-scriptrx.com/https://metabolicregen.com/

Oral Mucositis is probably the most common, debilitating complication of cancer surgery, chemotherapy and radiation. What is it, why is it common with cancer treatment, and what can you do about it? Stay tuned to find out. https://bit.ly/45XMELAWhat is Mucositis?Oral mucositis is inflammation in and around your mouth and can be a common symptom with treatment for cancer, including chemotherapy or radiation. Mucositis occurs when cancer treatments break down the rapidly divided cells that line the gastrointestinal tract, particularly in the mouth. In this Episode:01:44 - The Sharks of Rockaway Beach06:15 - Road Trip to Nebraska: A Famous Murder Spree and Birthplace of the Reuben Sandwich10:24 - Oral Mucositis: What it is, and Why it is Common with Cancer Treatment13:49 - Why it is Important to be Proactive to Prevent Mucositis, and Steps You Can Take21:30 - Mucositis Discussion & Recap on Prevention26:30 - Nutrition Tips for dehydration, taste changes and decreased appetite or pain while eating28:33 - Holly Butcher: Advice to World 24 Hours before She Died of Cancer30:47 - OutroSupport the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

The potential breakthrough in RNA vaccine technology has been increasingly discussed on social media. This episode looks at one promising study and its early, early results so far. UF GBM study: https://doi.org/10.1016/j.cell.2024.04.003 RNA Treatment Vaccine Review: https://doi.org/10.1002/ctm2.1384

Have you ever had a health concern that felt minor, but your gut told you to speak up anyway?In this episode, host Talaya Dendy shares a personal and timely story about the power of trusting your instincts, especially when it comes to your health. Drawing from her experience, she reveals how self-advocacy can be a life-saving tool, and why it's never a "false alarm" to speak up about your concerns.You'll discover how to:Recognize and honor your body's signals, even when they seem minor.Manage anxiety and build confidence in medical settings.Take charge of your health by transforming fear and uncertainty into empowered action.Turn your medical history into a powerful tool for better care.Whether you're newly diagnosed, in active treatment, or navigating life after cancer, this episode offers a powerful reminder that your voice matters. Talaya's story will help you feel more confident, informed, and supported on your health journey.✨Highlights from the show:08:59 A New Personal Story: My "False Alarm" Journey12:23 How to Advocate: Collaborating with Your Healthcare Team15:56 The Surprising Reason for My Pain17:21 Four Internal Self-Advocacy Strategies21:35 Closing Thoughts & Upcoming Survivor Series PreviewTranscript: https://bit.ly/podscript170Blog: https://www.ontheotherside.life/trusting-your-gut-why-it-s-never-a-false-alarm-in-self-advocacyNavigating Cancer TOGETHER delivers heartfelt stories and expert insights to remind you that you are not alone. Subscribe now on Spotify, Apple Podcasts, YouTube, or your favorite podcast platform.

Unlocking the Secrets of Cancer: IN8bio CEO William Ho, on Revolutionizing Cancer Treatment In8bio.com About the Guest(s): William Ho is the director, president, CEO, and co-founder of IN8bio, a biotechnology company focusing on immune cell technologies to combat diseases like cancer. With a career spanning nearly 24 years in the biotechnology and healthcare investment sectors, William previously served as managing partner at Aleph Point Capital and held positions with New Leaf Venture Partners. His extensive experience in venture capital and biotechnology has shaped his leadership in pioneering innovative treatments for cancer and other diseases. Episode Summary: In this engaging episode of The Chris Voss Show, host Chris Voss introduces listeners to the innovative world of biotechnology with William Ho, CEO and co-founder of IN8bio. With a keen focus on developing cutting-edge treatments using gamma delta T cells, William shares insights into his company's mission to tackle cancer's resilience by enhancing immune cell efficacy. Throughout the episode, William delves into the intricacies of gamma delta T cells and their role in combating cancer. He outlines how IN8bio's Del X platform harnesses the power of these cells to not only shrink cancerous tumors but eliminate residual cells that often cause resistance and recurrence. Highlighting the challenges and triumphs faced by biotechnology companies, he also reflects on his unique journey from Wall Street to leading a biotech firm—a path peppered with unexpected meetings and relentless pursuit for innovative solutions. Through personal anecdotes and expert insights, William underscores the importance of grit and perseverance in entrepreneurship, offering invaluable advice for aspiring biotech leaders. Key Takeaways: Gamma Delta T Cells: IN8bio is leveraging gamma delta T cells to improve cancer treatment by targeting and eliminating residual cancer cells. Entrepreneurial Journey: William Ho shared his path from Wall Street to biotech entrepreneur, emphasizing the importance of timing and unexpected opportunities. AI in Biotech: The company is exploring how artificial intelligence can enhance drug development and clinical trial efficiency, despite current challenges with data variability. IN8bio Success Stories: Notable clinical trial successes include patients with leukemia and glioblastoma remaining in remission after four years. Start-Up Challenges: Emphasizing resilience, William discusses the primal challenges and sacrifices entrepreneurs face, underscoring the role of grit in overcoming them. Notable Quotes: "Gamma delta T cells are a subset of our immune system. They're… white blood cells… that go out and hunt for cells that are pathogenic or are damaged or are cancerous." "Our goal is to attack the tumors when they're at their weakest early on…to try to ultimately eliminate them all." "Being an entrepreneur was much harder than I ever expected…the ability to suffer and just persevere." "If most investors knew the shit that goes wrong and how it goes wrong, they'd be terrified." "Go home, sit your wife down, and ask her, is she willing to suffer with me through this?"

Misinformation can spread quickly, especially when it comes to health care. Lately, some cancer patients have been asking about the use of Ivermectin, a drug designed to treat parasites, as a potential cancer treatment. Bayan Al-Share, M.D., Oncologist at Monument Health Cancer Care Institute, joins host Mark Houston to address where this idea came from, what the science actually says and how to evaluate sources of medical information. Dr. Al-Share also shares how she handles these conversations in the exam room and what patients should know before considering alternative therapies. Hosted on Acast. See acast.com/privacy for more information.

Do you like hearing interviews with world-changers?  Today you'll meet Dr. Nathan Goodyear who is with the Williams Cancer Institute where they are having phenomenal results with their treatments.  Dr. Goodyear will be sharing how his faith has intersected his profession his entire life.  Wonderful episode!Reach Out to Me:Website: www.dontignorethenudge.comPatreon: www.patreon.com/dontignorethenudgeIG: @dontignorethenudgepodcastPrivate FB group to WATCH interviews: www.dontignorethenudge.com/facebook__________________________________________________________________________________________Business/Personal Coaching with Cori:www.corifreeman.com(951) 923-2674Reach Out to Nathan Goodyear, MD:https://williamscancerinstitute.com/https://www.off-scriptrx.com/https://metabolicregen.com/

Dan Schmitt, President and CEO of Actuate Therapeutics, is developing a cancer therapy that inhibits GSK3β, a key enzyme that is hijacked in cancer cells to drive tumor growth. Inhibiting this enzyme can impact the cancer cells and stimulate an immune response against the tumor. Actuate selected metastatic pancreatic cancer as their first target due to unmet need and promising data for their lead drug candidate. This could represent a significant advancement in the treatment of metastatic pancreatic cancer, offering a new standard-of-care option.   Dan explains, "So, GSK-3β is a known quantity across a number of inflammatory diseases. It was understood when we first started the company that, particularly in cancer cells, GSK is hijacked in its activity. Basically it's been shown that in normal cells, GSK-3β sits in the cytoplasmic domain and there it's involved in multiple paths, basically in glucose metabolism. But in cancer cells, it translocates into the nuclear compartment, and there it's accumulated at much higher levels and then sits upstream of a pro-oncogenic set of pathways, all mediated by NF-κB. NF-κB is notorious in cancer. It regulates gene expression involved in tumor growth and progression, chemoresistance, and protects tumor cells from death." "So it's been very difficult to target NF-κB directly, but we can target GSK-3β directly, specifically and potently, and therefore downregulate those key oncogenic processes. And that's really where we started the company, that set of activities of this protein. What's been shown since we've been in the clinic is that there is also a resulting upregulation of immune response from the host towards the cancer itself based on this inhibition of GSK-3β as well."  #ActuateTherapeutics #Cancer #PancreaticCancer #MetastaticPancreaticCancer  actuatetherapeutics.com Download the transcript here

In this episode of Not Today Cancer – Conversations After the Bell, host Jen Delvaux sits down with Tiffany Roth, a breast cancer survivor who opens up about her powerful journey from diagnosis through recovery and into survivorship. Tiffany shares the emotional impact of hearing the words “you have cancer,” the difficult decisions she faced during treatment, and how she embraced lifestyle changes to support her healing. Jen and Tiffany discuss the often-overlooked emotional toll of cancer, the anxiety that can follow treatment, and the strength found in community and shared experiences. Tiffany also reveals how her blog became both an outlet and a purpose—helping others navigate their own diagnoses. Whether you're currently in treatment, post-treatment, or supporting someone you love, Tiffany's story is a reminder that survivorship is more than just healing physically—it's about finding connection, purpose, and a new way forward. Tiffany's Blog: https://checkyourrack.com Connect with Tiffany Here: https://www.instagram.com/checkyourrack

In this micro-episode, join Talaya Dendy as she redefines what it means to be calm, especially while navigating the challenges of living with cancer. Talaya shares powerful insights on stress management and the importance of being intentional with your energy and healing. She debunks common misconceptions about being calm and offers advice on how to find peace of mind by focusing on what you can control. Learn how to pause, assess, and make conscious choices about where you invest your energy. Whether you're a cancer survivor, caregiver, or simply looking to manage stress better, this episode provides actionable strategies for maintaining calm in challenging situations.Engage with Talaya and share your lessons from cancer by following her on Instagram at @cancerdoula_ontheotherside, LinkedIn at Talaya Dendy, and X at @NCTpodcastfan.✨Highlights from the show:00:00 Introduction: The Misconceptions of Being Calm00:38 The Power of Choosing Where You Focus Your Energy00:52 How to Find Peace of Mind Through Mindfulness01:27 Lessons on Healing and Resilience from Cancer02:00 Reflection and Community EngagementBlog: https://www.ontheotherside.life/the-quiet-strength-finding-calm-amidst-life-s-stormsTalaya is a seasoned cancer thriver who has navigated the many twists and turns of a cancer diagnosis and beyond.Whether you're a patient seeking encouragement or a caregiver looking for guidance, you'll find tips to help you manage energy, cultivate a sense of calm, and feel less alone. Tune in to find calm and community in the face of adversity.Transcript: https://bit.ly/podscript_calmFollow NCT: https://www.linkedin.com/company/navigating-cancer-together

In this thought-provoking episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Jeffrey Dach for a powerful discussion on bioidentical hormones, estrogen, and the myths that have shaped women's health for decades.Dr. Dach draws from over 40 years of clinical experience and research to challenge the mainstream narrative that estrogen causes breast cancer. Together, he and Dr. Jenn explore how estrogen protects DNA integrity, why natural progesterone is vastly different from synthetic progestins, and how iodine and testosterone play overlooked but vital roles in breast cancer prevention.Along the way, they trace the history of hormone therapies—from DES and Tamoxifen to modern-day aromatase inhibitors—revealing both the progress and the persistent dogmas of conventional medicine. This is a conversation about evidence, empowerment, and the urgent need to rethink how we approach women's health.Because of its depth and importance, this conversation has been divided into two parts. This episode is Part 1 of 2.In This Episode, You Will Learn:Why estrogen may protect against breast cancer rather than cause itThe truth about estrogen receptors and how they shape cancer riskThe critical difference between natural progesterone and synthetic progestinsHow testosterone supports breast cancer preventionWhy iodine deficiency remains a hidden driver of diseaseThe historical evolution of hormone therapies—from DES to TamoxifenHow entrenched medical dogmas persist despite new evidenceEpisode Timeline Highlights00:00 Introduction to Dr. Jeffrey Dach & the Hormone Debate 08:15 Breaking Away From Conventional Medical Training 16:32 Estrogen Receptors & The Women's Health Initiative Revisited 24:48 Estrogen as a Guardian of DNA Integrity & Historical Shifts in Cancer Treatment 33:10 Pregnancy, Hormones, & Breast Cancer Protection 41:22 Estriol, BiEst, & The Work of Dr. Rebecca Glazer 49:55 Iodine's Role in Breast & Thyroid Health 58:40 Progesterone Deficiency, Progestins, & Cancer Risk 1:07:12 Pharmaceutical Influence, Processed Foods, & Inflammatory Triggers 1:15:36 Fertility Decline, Chronic Disease, & Why Medical Beliefs Resist Change